Ole B. Suhr

18.3k citations

234 papers · 9.0k indexed · 1 hit paper · h-index 51

Impact in

Nephrology top 0.2%
- Parathyroid Disorders and Treatments
Molecular Biology top 0.5%
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Protein Kinase Regulation and GTPase Signaling

Papers in

Nephrology 42
- Parathyroid Disorders and Treatments 38
Molecular Biology 188
- Amyloidosis: Diagnosis, Treatment, Outcomes 183
- Protein Kinase Regulation and GTPase Signaling 19
- Ion channel regulation and function 18

Co-authors: Teresa Coelho Yukio Ando Gösta Holmgren Per Westermark David Adams Bo‐Göran Ericzon Lars Steen Mathew S. Maurer
Journals: Amyloid (51 papers)Journal of Internal Medicine (12 papers)Transplantation (11 papers)Orphanet Journal of Rare Diseases (10 papers)Scandinavian Journal of Gastroenterology (8 papers)
Partner nations: Sweden Japan France

In The Last Decade

Ole B. Suhr

231 papers receiving 8.8k citations

Hit Papers

align trajectories log scale

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis 2019 · 316 citations

Peers

Countries citing papers authored by Ole B. Suhr

Since Specialization

Citations

This map shows the geographic impact of Ole B. Suhr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole B. Suhr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole B. Suhr more than expected).

Fields of papers citing papers by Ole B. Suhr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole B. Suhr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole B. Suhr. The network helps show where Ole B. Suhr may publish in the future.

Co-authors

The 25 scholars most cited alongside Ole B. Suhr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ole B. Suhr Line = papers co-authored together Ole B. Suhr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis Orphanet Journal of Rare Diseases ·Teresa Coelho, David Adams, Isabel Conceição, Márcia Waddington‐Cruz, Hartmut Schmidt, Juan Buades, Josep M. Campistol, John L. Berk, Michael Polydefkis, Jing Jing Wang, Ji‐Hong Chen, Marianne T. Sweetser, Jared Gollob, Ole B. Suhr	2020	37
2	Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis Orphanet Journal of Rare Diseases ·Hedvig Paulsson Rokke, Nima Sadat Gousheh, Per Westermark, Ole B. Suhr, Intissar Anan, Elisabet Ihse, Björn Pilebro, Jonas Wixner	2020	30
3	Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis Circulation ·Scott D. Solomon, David Adams, Arnt V. Kristen, Martha Grogan, Alejandra González‐Duarte, Mathew S. Maurer, Giampaolo Merlini, Thibaud Damy, Michel Slama, Thomas H. Brannagan, Angela Dispenzieri, John L. Berk, Amil M. Shah, Pushkal Garg, Akshay Vaishnaw, Verena Karsten, Jihong Chen, Jared Gollob, Joshua R. Vest, Ole B. Suhr Hit paper breakdown →	2019	316
4	P.024 Long-term use of patisiran in patients with hereditary transthyretin amyloidosis (hATTR): 12 month efficacy & safety data from a global open label extension (OLE) study Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Alejandra González‐Duarte, T. Coelho, David Adams, Chih‐Chao Yang, Michael Polydefkis, Arnt V. Kristen, Ivaylo Tournev, Hartmut Schmidt, John L. Berk, Kuang-Hui Lin, PJ Gandhi, Marianne T. Sweetser, Matthew White, Jared Gollob, Ole B. Suhr, (unknown)	2019	2
5	Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis Clinical Autonomic Research ·Laura Obici, Ole B. Suhr	2019	26
6	Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families PLoS ONE ·Ole B. Suhr, Jonas Wixner, Intissar Anan, Hans-Erik Lundgren, Priyantha Wijayatunga, Per Westermark, Elisabet Ihse	2019	14
7	Infusion related reactions in patients with hATTR amyloidosis treated with patisiran Journal of the Peripheral Nervous System ·Michael Polydefkis, David Adams, Teresa Coelho, Arnt V. Kristen, Alejandra González‐Duarte, John L. Berk, Dianna Quan, Angela M. Partisano, Jared Gollob, Marianne Sweester, Jihong Chen, Ole B. Suhr	2018	2
8	Neuropathy progression in patients with hATTR amyloidosis : Analysis of the APOLLO placebo arm Journal of the Peripheral Nervous System ·P. James B. Dyck, David Adams, Teresa Coelho, Arnt V. Kristen, Alejandra González‐Duarte, John L. Berk, Angela M. Partisano, Jared Gollob, Marianne Sweester, Jihong Chen, Ole B. Suhr	2018	0
9	EFFECT OF PATISIRAN ON NERVE FIBER DENSITY AND AMYLOID CONTENT IN SKIN : RESULTS FROM PHASE 2 OPEN LABEL EXTENSION (OLE) STUDY IN HATTR AMYLOIDOSIS Journal of the Peripheral Nervous System ·Michael Polydefkis, Gigi J. Ebenezer, David Adams, T. Coelho, Isabel Conceição, Márcia Waddington‐Cruz, Hartmut Schmidt, Juan Manuel Buades, Josep M. Campistol, J Pouget, John L. Berk, Angela M. Partisano, Jackie Chen, Jared Gollob, Ole B. Suhr	2017	1
10	Burden of Illness for Patients with Hereditary Attr Amyloidosis with Polyneuropathy Begins with Symptom Onset and Increases with Disease Progression Value in Health ·RN Denoncourt, David Adams, Alejandra González‐Duarte, W. O'Riordan, Chih‐Chao Yang, Taro Yamashita, Arnt V. Kristen, Ivaylo Tournev, Hartmut Schmidt, Teresa Coelho, John L. Berk, Kong-Ping Lin, J. Chen, Jared Gollob, Ole B. Suhr	2016	3
11	Interim results from phase ii trial of aln-ttr02, a novel RNAi therapeutic for the treatment of familial amyloidotic polyneuropathy Journal of the Peripheral Nervous System ·David Adams, Teresa Coelho, Ole B. Suhr, Isabel Conceição, Márcia Waddington‐Cruz, Hartmut Schmidt, Josep M. Campistol, J Pouget, Juan Manuel Buades, Rick Falzone, Jamie Harrop, Rosa de Llanos, Jason Butler, Jeff Cehelsky, Sara Nochur, Akshay Vaishnaw, Jared Gollob	2013	2
12	ALN-TTR, an RNAI therapeutic for the treatment of transthyretin amyloidosis Nucleic Acid Therapeutics ·Dinah W.Y. Sah, Qingmin Chen, Susete Costelha, Jim Butler, Shannon Fishman, Anthony Rossomando, Lubomir V. Nechev, Maria João Saraiva, Teresa Coelho, Ole B. Suhr, David Adams, Pierre Lozeron, Philip N. Hawkins, Timothy Mant, Renta Hutabarat, Rick Falzone, Jeff Cehelsky, Yaysie Figueroa, Akshay Vaishnaw, Jared Gollob	2011	1
13	Report and recommendations from the 1st International Workshop on the Hereditary Renal Amyloidoses, FAP Symposium, London, 2008 Amyloid ·Arie J. Stangou, Luísa Lobato, Steven R. Zeldenrust, Bernard Portmann, R. P. Linke, G. F. Otto, H Wilczek, Ole B. Suhr, David Azoulay, Gilles Grateau, Maria M. Picken, Justin O’Grady, B.-G. Ericzon, Nigel Heaton, M D Benson	2010	5
14	A first case of liver rupture in transthyretin (TTR) familial amyloid polyneuropathy M Michowska, Ewá Boj, T Wrzołkowa, Irene Jablo ́nska-Kaszewska, Krzysztof Bielawsk, Ole B. Suhr, Gösta Holmgren, Bogdan Falkiewicz	2005	2
15	Hereditary transthyretin amyloidosis from a Scandinavian perspective Journal of Internal Medicine ·Ole B. Suhr, Ida Hastrup Svendsen, Rune Andersson, Anna Danielsson, Gösta Holmgren, P Ranløv	2003	78
16	Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP) Amyloid ·Yukio Ando, Ole B. Suhr	1998	69
17	Impact of liver transplantation on autonomic neuropathy in familial amyloidotic polyneuropathy: an evaluation by spectral analysis of heart rate variability Journal of Internal Medicine ·Ole B. Suhr, Urban Wiklund, Yukio Ando, Eiko Ando, B O Olofsson	1997	25
18	Quality of life after liver transplantation in patients with familial amyloidotic polyneuropathy Amyloid ·Elisabeth Jonsén, Ole B. Suhr, Elsy Athlin, Lars Wikström	1996	13
19	A New Simple and Rapid Screening Method for Variant Transthyretin-Related Amyloidosis Biochemical and Biophysical Research Communications ·Yukio Ando, Per‐Ingvar Ohlsson, Ole B. Suhr, Nils Nyhlin, Taro Yamashita, Gösta Holmgren, Åke Danielsson, Ola Sandgren, Makoto Uchino, Masayuki Ando	1996	61
20	Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology. Gut ·Anna Danielsson, Henry Nyhlin, H. Persson, U Stendahl, Roger Stenling, Ole B. Suhr	1991	71

About Ole B. Suhr

Ole B. Suhr is a scholar working on Nephrology, Molecular Biology, Cardiology and Cardiovascular Medicine, Genetics and Epidemiology, having authored 234 papers that have together received 9.0k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (183 papers), Parathyroid Disorders and Treatments (38 papers), Alzheimer's disease research and treatments (21 papers), Peptidase Inhibition and Analysis (21 papers), Pneumocystis jirovecii pneumonia detection and treatment (20 papers), Neuroendocrine Tumor Research Advances (20 papers), Protein Kinase Regulation and GTPase Signaling (19 papers) and Ion channel regulation and function (18 papers). The work is most often cited by research in Nephrology (1.6k citations), Molecular Biology (7.3k citations), Cell Biology (1.3k citations), Genetics (775 citations) and Rheumatology (997 citations). Ole B. Suhr has collaborated with scholars based in Sweden, Japan and France. Frequent co-authors include Teresa Coelho, Yukio Ando, Gösta Holmgren, Per Westermark, David Adams, Bo‐Göran Ericzon, Lars Steen, Mathew S. Maurer, Per Lindqvist and Philip N. Hawkins. Their work appears in journals such as Amyloid, Journal of Internal Medicine, Transplantation, Orphanet Journal of Rare Diseases and Scandinavian Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact